申请人:Warner-Lambert Company
公开号:US04929734A1
公开(公告)日:1990-05-29
Certain N-substituted 1-(1,2,3,6-tetrahydro-3-pyridinyl)oximes and N-substituted 1-(1,2,3,6-tetrahydro-4-pyridinyl)oximes are useful as sigma binding agents for the treatment of depression, psychoses and/or inflammatory diseases.
某些N取代的1-(1,2,3,6-四氢-3-吡啶基)肟和N取代的1-(1,2,3,6-四氢-4-吡啶基)肟可用作σ结合剂,用于治疗抑郁症、精神病和/或炎症性疾病。